Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05183919 · ClinicalTrials.gov registry record · NA

Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult)

A NA study, sponsored by Akili Interactive Labs.

Completed
Registry status
NA
Development phase
223
Enrollment target

NCT05183919 is a NA study that has completed, run by Akili Interactive Labs. The registered enrollment target is 223 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05183919, a NA study, has completed, sponsored by Akili Interactive Labs.

COMPLETED
Registry status
NA
Development phase
223 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effects of the videogame-like digital therapy on attentional functioning and symptoms in Adults diagnosed with ADHD.

Interventions

  • OTHER Digital Treatment

Trial Details

FieldValue
Enrollment Target 223 participants
Start Date 2021-11-29
Est. Completion 2023-01-13
Phase NA

Sponsor

Akili Interactive Labs

13 total trials

What the Registry Record Tells You About NCT05183919

The ClinicalTrials.gov registry entry for NCT05183919 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akili Interactive Labs, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Digital Treatment is the first listed.

NCT05183919 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05183919 about?

NCT05183919 is a clinical study titled "Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult)". The purpose of this study is to evaluate the effects of the videogame-like digital therapy on attentional functioning and symptoms in Adults diagnosed with ADHD.

What is the current status of trial NCT05183919?

This trial is currently completed. It is a NA study. The enrollment target is 223 participants. The study started on 2021-11-29. Estimated completion is 2023-01-13.

What interventions are being tested in trial NCT05183919?

The interventions under investigation include: Digital Treatment (OTHER).

Who is sponsoring clinical trial NCT05183919?

This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.